Oric Pharmaceuticals, Inc.
ORIC- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001796280
In the last 90 days, Oric Pharmaceuticals, Inc. insiders filed 0 open-market purchases and 4 sales; 180 institutions reported holding it in 13F filings for Q2 2026, worth $1.34B in total; Viking Global Investors is the only superinvestor holding it.
13F holders, Q4 2024
Institutional positions in Oric Pharmaceuticals, Inc. as of Dec 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 129
- +7 vs. Q3 2024
- Shares held
- 75.8M
- +5.97M (+8.6%) vs. Q3 2024
- Total value
- $611.7M
- −$103.4M (−14.5%) vs. Q3 2024
- New holders
- 27
- 51 more added
- Sold out
- 20
- 26 more reduced
Compare with Q3 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ORIC on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 180 | $1.34B |
| Q1 2026 | 182 | $1.51B |
| Q4 2025 | 165 | $979.6M |
| Q3 2025 | 152 | $1.28B |
| Q2 2025 | 142 | $947.6M |
| Q1 2025 | 143 | $442.0M |
| Q4 2024 | 129 | $611.7M |
| Q3 2024 | 122 | $715.1M |
| Q2 2024 | 113 | $478.3M |
| Q1 2024 | 112 | $879.3M |
| Q4 2023 | 92 | $465.9M |
| Q3 2023 | 90 | $290.7M |
| Q2 2023 | 83 | $353.4M |
| Q1 2023 | 71 | $188.5M |
| Q4 2022 | 64 | $192.1M |
| Q3 2022 | 76 | $104.6M |
| Q2 2022 | 83 | $147.1M |
| Q1 2022 | 101 | $181.7M |
| Q4 2021 | 80 | $512.1M |
| Q3 2021 | 82 | $762.1M |
| Q2 2021 | 78 | $639.4M |
| Q1 2021 | 82 | $874.3M |
Institutions, Q4 2024
Shares, value and share of portfolio for each institution holding Oric Pharmaceuticals, Inc.; share changes are against Q3 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Dimensional Fund Advisors LP | 717,188 | $5.79M | 0.00% | +103,237+16.8% | Added |
| Schonfeld Strategic Advisors LLC | 724,319 | $5.85M | 0.04% | +724,319 | New |
| Franklin Resources Inc | 950,522 | $7.67M | 0.00% | +630.0% | Added |
| Euclidean Capital LLC | 989,410 | $7.98M | 1.08% | 00.0% | Unchanged |
| Siren, L.L.C. | 1,007,575 | $8.13M | 0.36% | 00.0% | Unchanged |
| Silverarc Capital Management, LLC | 1,178,300 | $9.51M | 2.13% | +78,810+7.2% | Added |
| Avidity Partners Management LP | 1,265,200 | $10.2M | 1.02% | −181,919−12.6% | Reduced |
| Vivo Capital, LLC | 1,277,818 | $10.3M | 1.16% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 1,278,713 | $10.3M | 0.00% | +5,200+0.4% | Added |
| Price T Rowe Associates Inc | 1,295,025 | $10.5M | 0.00% | +180,140+16.2% | Added |
| ArrowMark Colorado Holdings LLC | 1,395,352 | $11.3M | 0.15% | +40,844+3.0% | Added |
| First Turn Management, LLC | 1,451,037 | $11.7M | 2.10% | 00.0% | Unchanged |
| Balyasny Asset Management LLC | 1,555,260 | $12.6M | 0.03% | +424,194+37.5% | Added |
| NEA Management Company, LLC | 1,566,081 | $12.6M | 0.71% | +66,081+4.4% | Added |
| Superstring Capital Management LP | 1,580,745 | $12.8M | 11.20% | +631,223+66.5% | Added |
| Boxer Capital Management, LLC | 1,732,571 | $14.0M | 1.19% | +1,732,571 | New |
| State Street Corp | 1,846,262 | $14.9M | 0.00% | −91,907−4.7% | Reduced |
| Commodore Capital LP | 2,000,000 | $16.1M | 1.18% | 00.0% | Unchanged |
| FMR LLC | 2,467,809 | $19.9M | 0.00% | −1,911,010−43.6% | Reduced |
| Vanguard Group Inc | 3,203,789 | $25.9M | 0.00% | +36,478+1.2% | Added |
| EcoR1 Capital, LLC | 3,418,068 | $27.6M | 1.11% | 00.0% | Unchanged |
| The Column Group LLC | 3,540,777 | $28.6M | 51.26% | 00.0% | Unchanged |
| Frazier Life Sciences Management, L.P. | 3,888,238 | $31.4M | 1.30% | −254,617−6.1% | Reduced |
| Alkeon Capital Management LLC | 3,904,096 | $31.5M | 0.18% | 00.0% | Unchanged |
| VR Adviser, LLC | 4,394,527 | $35.5M | 2.43% | 00.0% | Unchanged |
| Viking Global Investors LPSuperinvestorViking Global Investors | 4,431,008 | $35.8M | 0.12% | +431,008+10.8% | Added |
| BlackRock, Inc. | 5,113,034 | $41.3M | 0.00% | +11,217+0.2% | Added |
| Nextech Invest AG | 5,285,714 | $42.7M | 6.92% | 00.0% | Unchanged |
| Pfizer Inc | 5,376,344 | $43.4M | 1.67% | +5,376,344 | New |
| Boxer Capital, LLC | 0 | $0 | 0.00% | −1,732,571−100.0% | Sold out |
| Driehaus Capital Management LLC | 0 | $0 | 0.00% | −119,083−100.0% | Sold out |
| Deerfield Management Company, L.P. (Series C) | 0 | $0 | 0.00% | −78,435−100.0% | Sold out |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −47,849−100.0% | Sold out |
| EntryPoint Capital, LLC | 0 | $0 | 0.00% | −28,580−100.0% | Sold out |
| Campbell & CO Investment Adviser LLC | 0 | $0 | 0.00% | −27,241−100.0% | Sold out |
| Trexquant Investment LP | 0 | $0 | 0.00% | −25,220−100.0% | Sold out |
| Corton Capital Inc. | 0 | $0 | 0.00% | −17,440−100.0% | Sold out |
| Squarepoint Ops LLC | 0 | $0 | 0.00% | −16,666−100.0% | Sold out |
| Renaissance Technologies LLC | 0 | $0 | 0.00% | −13,700−100.0% | Sold out |
| Connor, Clark & Lunn Investment Management Ltd. | 0 | $0 | 0.00% | −12,832−100.0% | Sold out |
| Creative Planning | 0 | $0 | 0.00% | −11,272−100.0% | Sold out |
| Ameriprise Financial Inc | 0 | $0 | 0.00% | −11,109−100.0% | Sold out |
| LPL Financial LLC | 0 | $0 | 0.00% | −10,731−100.0% | Sold out |
| Cornercap Investment Counsel Inc | 0 | $0 | 0.00% | −10,063−100.0% | Sold out |
| Acadian Asset Management LLC | 0 | $0 | 0.00% | −2,309−100.0% | Sold out |
| Smartleaf Asset Management LLC | 0 | $0 | 0.00% | −870−100.0% | Sold out |
| NBC Securities, Inc. | 0 | $0 | 0.00% | −118−100.0% | Sold out |
| Bessemer Group Inc | 0 | $0 | 0.00% | −120−100.0% | Sold out |
| Capital Performance Advisors LLP | 0 | $0 | 0.00% | −1−100.0% | Sold out |